Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease.

Shukla SD, Walters EH, Simpson JL, Keely S, Wark PAB, O'Toole RF, Hansbro PM.

Respirology. 2019 Oct 30. doi: 10.1111/resp.13722. [Epub ahead of print] Review.

2.

A step-by-step beginner's protocol for whole genome sequencing of human bacterial pathogens.

Gautam SS, Kc R, Leong KW, Mac Aogáin M, O'Toole RF.

J Biol Methods. 2019 Mar 15;6(1):e110. doi: 10.14440/jbm.2019.276. eCollection 2019.

3.

Intercontinental translocation of latent multidrug-resistant tuberculosis to Australia demonstrated by whole genome sequencing.

Gautam SS, Haug G, Cooley LA, Mac Aogáin M, O'Toole RF.

Med J Aust. 2019 Mar;210(5):236-236.e1. doi: 10.5694/mja2.50044. Epub 2019 Feb 21. No abstract available.

PMID:
30793313
4.

The role of environmental exposure to non-cigarette smoke in lung disease.

Kc R, Shukla SD, Gautam SS, Hansbro PM, O'Toole RF.

Clin Transl Med. 2018 Dec 5;7(1):39. doi: 10.1186/s40169-018-0217-2. Review.

5.

The host microbiome and impact of tuberculosis chemotherapy.

O'Toole RF, Gautam SS.

Tuberculosis (Edinb). 2018 Dec;113:26-29. doi: 10.1016/j.tube.2018.08.015. Epub 2018 Sep 1. Review.

PMID:
30514510
6.

Role of Oxidative Stress in the Pathology and Management of Human Tuberculosis.

Shastri MD, Shukla SD, Chong WC, Dua K, Peterson GM, Patel RP, Hansbro PM, Eri R, O'Toole RF.

Oxid Med Cell Longev. 2018 Oct 11;2018:7695364. doi: 10.1155/2018/7695364. eCollection 2018. Review.

7.

Development of a New Genome-Wide MLST Scheme for High-Resolution Typing of Diverse Mycobacterium tuberculosis Complex Strains.

O'Toole RF.

EBioMedicine. 2018 Aug;34:6-7. doi: 10.1016/j.ebiom.2018.07.038. Epub 2018 Aug 4.

8.

Progress in the Development of Platelet-Activating Factor Receptor (PAFr) Antagonists and Applications in the Treatment of Inflammatory Diseases.

Hyland IK, O'Toole RF, Smith JA, Bissember AC.

ChemMedChem. 2018 Sep 19;13(18):1873-1884. doi: 10.1002/cmdc.201800401. Epub 2018 Aug 16. Review.

PMID:
30009544
9.

Draft Genome Sequence of New Vancomycin-Resistant Enterococcus faecium Sequence Type 1421.

Leong KWC, Cooley LA, O'Toole RF.

Genome Announc. 2018 May 17;6(20). pii: e00438-18. doi: 10.1128/genomeA.00438-18.

10.

Emergence of Vancomycin-Resistant Enterococcus faecium at an Australian Hospital: A Whole Genome Sequencing Analysis.

Leong KWC, Cooley LA, Anderson TL, Gautam SS, McEwan B, Wells A, Wilson F, Hughson L, O'Toole RF.

Sci Rep. 2018 Apr 19;8(1):6274. doi: 10.1038/s41598-018-24614-6.

11.

Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case.

Gautam SS, Mac Aogáin M, Cooley LA, Haug G, Fyfe JA, Globan M, O'Toole RF.

PLoS One. 2018 Feb 21;13(2):e0192351. doi: 10.1371/journal.pone.0192351. eCollection 2018.

12.
13.

Draft Genome Sequence of the First Confirmed Isolate of Multidrug-Resistant Mycobacterium tuberculosis in Tasmania.

Gautam SS, Mac Aogáin M, O'Toole RF.

Genome Announc. 2017 Nov 2;5(44). pii: e01230-17. doi: 10.1128/genomeA.01230-17.

14.

Molecular epidemiology of multi- and extensively-drug-resistant Mycobacterium tuberculosis in Ireland, 2001-2014.

Roycroft E, O'Toole RF, Fitzgibbon MM, Montgomery L, O'Meara M, Downes P, Jackson S, O'Donnell J, Laurenson IF, McLaughlin AM, Keane J, Rogers TR.

J Infect. 2018 Jan;76(1):55-67. doi: 10.1016/j.jinf.2017.10.002. Epub 2017 Oct 12.

PMID:
29031637
15.

Limitations of the Mycobacterium tuberculosis reference genome H37Rv in the detection of virulence-related loci.

O'Toole RF, Gautam SS.

Genomics. 2017 Oct;109(5-6):471-474. doi: 10.1016/j.ygeno.2017.07.004. Epub 2017 Jul 22. Review.

16.

Differential carriage of virulence-associated loci in the New Zealand Rangipo outbreak strain of Mycobacterium tuberculosis.

Gautam SS, Mac Aogáin M, Bower JE, Basu I, O'Toole RF.

Infect Dis (Lond). 2017 Sep;49(9):680-688. doi: 10.1080/23744235.2017.1330553. Epub 2017 May 23.

PMID:
28535727
17.

Temporal upregulation of host surface receptors provides a window of opportunity for bacterial adhesion and disease.

Kc R, Shukla SD, Walters EH, O'Toole RF.

Microbiology. 2017 Apr;163(4):421-430. doi: 10.1099/mic.0.000434. Epub 2017 Apr 6. Review.

PMID:
28113047
18.

Relating annual migration from high tuberculosis burden country of origin to changes in foreign-born tuberculosis notification rates in low-medium incidence European countries.

Hanway A, Comiskey CM, Tobin K, O'Toole RF.

Tuberculosis (Edinb). 2016 Dec;101:67-74. doi: 10.1016/j.tube.2016.07.019. Epub 2016 Aug 6.

PMID:
27865401
19.
20.

An antagonist of the platelet-activating factor receptor inhibits adherence of both nontypeable Haemophilus influenzae and Streptococcus pneumoniae to cultured human bronchial epithelial cells exposed to cigarette smoke.

Shukla SD, Fairbairn RL, Gell DA, Latham RD, Sohal SS, Walters EH, O'Toole RF.

Int J Chron Obstruct Pulmon Dis. 2016 Jul 25;11:1647-55. doi: 10.2147/COPD.S108698. eCollection 2016.

21.

Draft Genome Sequence of a New Zealand Rangipo Strain of Mycobacterium tuberculosis.

Mac Aogáin M, Gautam SS, Bower JE, Basu I, O'Toole RF.

Genome Announc. 2016 Jul 7;4(4). pii: e00657-16. doi: 10.1128/genomeA.00657-16.

22.

Convergence in the Epidemiology and Pathogenesis of COPD and Pneumonia.

Gautam SS, O'Toole RF.

COPD. 2016 Dec;13(6):790-798. Epub 2016 Jun 16. Review.

PMID:
27310416
23.

TB meets COPD: An emerging global co-morbidity in human lung disease.

O'Toole RF, Shukla SD, Walters EH.

Tuberculosis (Edinb). 2015 Dec;95(6):659-663. doi: 10.1016/j.tube.2015.08.005. Epub 2015 Sep 2. Review.

PMID:
26386744
24.

Platelet activating factor receptor: gateway for bacterial chronic airway infection in chronic obstructive pulmonary disease and potential therapeutic target.

Shukla SD, Sohal SS, O'Toole RF, Eapen MS, Walters EH.

Expert Rev Respir Med. 2015 Aug;9(4):473-85. doi: 10.1586/17476348.2015.1070673. Review.

PMID:
26207607
25.

Draft Genome Sequence of a Drug-Susceptible New Zealand Isolate of Mycobacterium tuberculosis Lineage 3.

Mac Aogáin M, Bower JE, Basu I, Freeman JT, O'Toole RF.

Genome Announc. 2015 May 21;3(3). pii: e00499-15. doi: 10.1128/genomeA.00499-15.

26.

Development of a Mycobacterium smegmatis transposon mutant array for characterising the mechanism of action of tuberculosis drugs: Findings with isoniazid and its structural analogues.

Campen RL, Ackerley DF, Cook GM, O'Toole RF.

Tuberculosis (Edinb). 2015 Jul;95(4):432-9. doi: 10.1016/j.tube.2015.03.012. Epub 2015 Apr 17.

PMID:
25936537
27.

Tuberculosis incidence in the Irish Traveller population in Ireland from 2002 to 2013.

O'Toole RF, Jackson S, Hanway A, O'Donnell J, Comiskey CM, Rogers TR, O'Flanagan D.

Epidemiol Infect. 2015 Oct;143(13):2849-55. doi: 10.1017/S0950268815000138. Epub 2015 Feb 12.

PMID:
25672344
28.

Whole genome sequencing: a new paradigm in the surveillance and control of human tuberculosis.

Hasnain SE, O'Toole RF, Grover S, Ehtesham NZ.

Tuberculosis (Edinb). 2015 Mar;95(2):91-4. doi: 10.1016/j.tube.2014.12.007. Epub 2014 Dec 31. Review.

PMID:
25586521
29.

Draft Genome Sequence of a Multidrug-Resistant New Zealand Isolate of Mycobacterium tuberculosis Lineage 3.

Mac Aogáin M, Johari BM, Bower JE, O'Toole RF.

Genome Announc. 2014 Oct 16;2(5). pii: e01017-14. doi: 10.1128/genomeA.01017-14.

30.

Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in Ireland.

Roycroft E, Mac Aogáin M, O'Toole RF, Fitzgibbon M, Rogers TR.

Genome Announc. 2014 Oct 9;2(5). pii: e01002-14. doi: 10.1128/genomeA.01002-14.

31.

Identification and bioactivity of 3-epi-xestoaminol C isolated from the New Zealand brown alga Xiphophora chondrophylla.

Dasyam N, Munkacsi AB, Fadzilah NH, Senanayake DS, O'Toole RF, Keyzers RA.

J Nat Prod. 2014 Jun 27;77(6):1519-23. doi: 10.1021/np500171z. Epub 2014 May 23.

PMID:
24856903
32.

Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in New Zealand.

O'Toole RF, Johari BM, Mac Aogáin M, Rogers TR, Bower JE, Basu I, Freeman JT.

Genome Announc. 2014 May 8;2(3). pii: e00319-14. doi: 10.1128/genomeA.00319-14.

33.

Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen.

Bassett IM, Lun S, Bishai WR, Guo H, Kirman JR, Altaf M, O'Toole RF.

J Microbiol. 2013 Oct;51(5):651-8. doi: 10.1007/s12275-013-3099-4. Epub 2013 Jun 25.

PMID:
23800952
34.

Molecular epidemiology of human tuberculosis in New Zealand and potential insights for disease control.

O'Toole RF, Freeman JT.

N Z Med J. 2013 Apr 19;126(1373):100-2. No abstract available.

PMID:
23797087
35.

Phylogenetic lineages of tuberculosis isolates in New Zealand and their association with patient demographics.

Yen S, Bower JE, Freeman JT, Basu I, O'Toole RF.

Int J Tuberc Lung Dis. 2013 Jul;17(7):892-7. doi: 10.5588/ijtld.12.0795. Epub 2013 Apr 30.

PMID:
23635796
36.

Navigating tuberculosis drug discovery with target-based screening.

Miller CH, O'Toole RF.

Expert Opin Drug Discov. 2011 Aug;6(8):839-54. doi: 10.1517/17460441.2011.586999. Epub 2011 May 25.

PMID:
22651126

Supplemental Content

Loading ...
Support Center